Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Liabilities and Shareholders Equity (2019 - 2025)

Historic Liabilities and Shareholders Equity for Outset Medical (OM) over the last 7 years, with Q4 2025 value amounting to $264.5 million.

  • Outset Medical's Liabilities and Shareholders Equity fell 409.69% to $264.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.1 billion, marking a year-over-year decrease of 794.64%. This contributed to the annual value of $264.5 million for FY2025, which is 409.69% down from last year.
  • Latest data reveals that Outset Medical reported Liabilities and Shareholders Equity of $264.5 million as of Q4 2025, which was down 409.69% from $277.3 million recorded in Q3 2025.
  • Over the past 5 years, Outset Medical's Liabilities and Shareholders Equity peaked at $504.8 million during Q2 2021, and registered a low of $264.5 million during Q4 2025.
  • In the last 5 years, Outset Medical's Liabilities and Shareholders Equity had a median value of $340.3 million in 2023 and averaged $355.8 million.
  • As far as peak fluctuations go, Outset Medical's Liabilities and Shareholders Equity soared by 1476.74% in 2021, and later plummeted by 2518.02% in 2022.
  • Over the past 5 years, Outset Medical's Liabilities and Shareholders Equity (Quarter) stood at $463.5 million in 2021, then decreased by 13.67% to $400.1 million in 2022, then dropped by 21.57% to $313.8 million in 2023, then fell by 12.11% to $275.8 million in 2024, then decreased by 4.1% to $264.5 million in 2025.
  • Its Liabilities and Shareholders Equity was $264.5 million in Q4 2025, compared to $277.3 million in Q3 2025 and $288.8 million in Q2 2025.